Sterne Kessler Wins $9.5 Million Jury Verdict for Mallinckrodt Pharmaceuticals in Patent Suit

Carbonatix Pre-Player Loader

Audio By Carbonatix

WASHINGTON--(BUSINESS WIRE)--Sep 16, 2025--

Sterne, Kessler, Goldstein & Fox won a $9.5 million jury verdict on behalf of Mallinckrodt Pharmaceuticals in a patent infringement lawsuit filed in the U.S. District Court for the District of Delaware over Mallinckrodt’s INOmax (nitric oxide for inhalation) drug product and associated nitric oxide delivery device.

Mallinckrodt first brought suit under the Hatch-Waxman Act against Airgas Therapeutics in 2022, arguing that Airgas’s Abbreviated New Drug Application for a generic version of INOmax as well as Airgas’s nitric oxide delivery device infringed on Mallinckrodt’s patents. In 2023, Airgas obtained FDA approval to commercially sell its generic drug product in the United States and subsequently began commercial activity. The Delaware jury found that Airgas infringed all seven asserted claims of the three patents and that Airgas’s infringement was willful. The jury awarded $9.5 million in damages for Airgas’s at-risk launch.

The Sterne Kessler team representing Mallinckrodt was led by director Dennies Varughese. Director Deirdre Wells served as lead trial counsel, delivering opening statements and closing arguments. They were joined by:

The case is Mallinckrodt Pharmaceuticals Ireland Ltd. et al. v. Airgas Therapeutics LLC et al. (D. Del., 1:22cv01648).

About Sterne, Kessler, Goldstein & Fox

Based in Washington, D.C. and renowned for more than four decades for dedication to the protection, enhancement, and enforcement of intellectual property rights, Sterne, Kessler, Goldstein & Fox is one of the most highly regarded intellectual property specialty law firms in the world. Its team of attorneys, registered patent agents, technical specialists, specialized trademark paralegals, and law clerks include some of the country’s most respected practitioners of IP law, tackling innovations across a broad spectrum of industries. The firm’s practitioners represent Fortune 500 companies, entrepreneurs, start-ups, inventors, venture capital firms, and universities in a client service driven environment that is welcoming, inclusive, and intellectually stimulating. Visit the firm online at sternekessler.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250916231741/en/

CONTACT: Kimberly Doughty

Senior Marketing Manager

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA DISTRICT OF COLUMBIA

INDUSTRY KEYWORD: PROFESSIONAL SERVICES HEALTH MEDICAL DEVICES LEGAL GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Sterne, Kessler, Goldstein & Fox

Copyright Business Wire 2025.

PUB: 09/16/2025 10:27 AM/DISC: 09/16/2025 10:26 AM

http://www.businesswire.com/news/home/20250916231741/en

 

Trending Videos

Salem News Channel Today

Sponsored Links

Trending Videos

On Air & Up Next

  • Investor's Edge
    8:00PM - 9:00PM
     
    Gary Kaltbaum is a hard hitting and pull-no-punches host especially when it   >>
     
  • InvestTalk with Justin Klein and Luke Guerrero
     
    InvestTalk™ serves as your go-to educational platform to delve into the   >>
     
  • New Focus on Wealth
    10:00PM - 11:00PM
     
    Each day Rob Black and CFP Chad Burton will filter through the “noise” on Wall   >>
     
  • Radio Yesteryear
    11:00PM - 12:00AM
     
    Tune in for the best of the golden age of radio on “Radio Yesteryear”, as   >>
     
  • Plan Your Estate Radio
    12:00AM - 1:00AM
     
    Many Americans do not have an estate plan, which means when they die, the   >>
     

See the Full Program Guide